QIAGEN Price to Book Ratio 2006-2021 | QGEN

Historical price to book ratio values for QIAGEN (QGEN) over the last 10 years. The current price to book ratio for QIAGEN as of October 22, 2021 is 4.13.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

QIAGEN Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 53.99 4.15
2021-06-30 48.38 $13.02 3.71
2021-03-31 48.69 $12.48 3.90
2020-12-31 52.85 $12.27 4.31
2020-09-30 52.26 $11.85 4.41
2020-06-30 42.81 $11.47 3.73
2020-03-31 41.60 $10.92 3.81
2019-12-31 33.80 $11.14 3.03
2019-09-30 32.97 $10.89 3.03
2019-06-30 40.55 $11.62 3.49
2019-03-31 40.68 $11.29 3.60
2018-12-31 34.45 $11.68 2.95
2018-09-30 37.88 $11.17 3.39
2018-06-30 36.16 $10.93 3.31
2018-03-31 32.31 $11.18 2.89
2017-12-31 30.93 $11.22 2.76
2017-09-30 31.50 $11.34 2.78
2017-06-30 33.53 $10.98 3.05
2017-03-31 28.97 $10.53 2.75
2016-12-31 29.10 $11.11 2.62
2016-09-30 28.50 $11.55 2.47
2016-06-30 22.65 $11.66 1.94
2016-03-31 23.20 $11.68 1.99
2015-12-31 28.71 $11.02 2.61
2015-09-30 26.81 $11.24 2.39
2015-06-30 25.74 $11.32 2.27
2015-03-31 26.17 $11.06 2.37
2014-12-31 24.36 $11.90 2.05
2014-09-30 23.65 $11.76 2.01
2014-06-30 25.39 $12.29 2.07
2014-03-31 21.90 $11.84 1.85
2013-12-31 24.73 $12.09 2.04
2013-09-30 22.22 $11.85 1.87
2013-06-30 20.68 $11.50 1.80
2013-03-31 21.89 $11.69 1.87
2012-12-31 18.85 $12.06 1.56
2012-09-30 19.22 $11.91 1.61
2012-06-30 17.34 $11.63 1.49
2012-03-31 16.17 $11.62 1.39
2011-12-31 14.34 $11.34 1.26
2011-09-30 14.36 $11.46 1.25
2011-06-30 19.75 0.00
2011-03-31 20.82 0.00
2010-12-31 20.30 $11.03 1.84
2010-09-30 18.42 0.00
2010-06-30 19.96 0.00
2010-03-31 23.87 0.00
2009-12-31 23.19 $10.25 2.26
2009-09-30 22.10 0.00
2009-06-30 19.31 0.00
2009-03-31 16.57 0.00
2008-12-31 18.24 0.00
2008-09-30 20.49 0.00
2008-06-30 20.90 0.00
2008-03-31 21.60 0.00
2007-12-31 21.86 0.00
2007-09-30 20.16 0.00
2007-06-30 18.47 0.00
2007-03-31 17.84 0.00
2006-12-31 15.71 0.00
2006-09-30 16.45 0.00
2006-06-30 14.25 0.00
2006-03-31 15.48 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.309B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76